리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 10월
페이지 정보:영문 186 Pages
라이선스 & 가격 (부가세 별도)
한글목차
펨테크 세계 시장 규모는 2030년까지 1,070억 달러에 달할 것으로 전망
2023년 366억 달러로 추정되는 펨테크 세계 시장은 2030년에는 1,070억 달러에 달할 것으로 예상되며, 2023-2030년 분석 기간 동안 16.6%의 CAGR로 성장할 것으로 예상됩니다. 이 보고서에서 분석하는 부문 중 하나인 펨테크 디바이스는 16.8%의 CAGR을 기록하며 분석 기간 종료 시점에 388억 달러에 달할 것으로 예상됩니다. 펨테크 소프트웨어 분야의 성장률은 분석 기간 동안 CAGR 18.1%로 추정됩니다.
미국 시장 96억 달러, 중국 CAGR 15.5%로 성장 전망
미국의 펨테크 시장 규모는 2023년 96억 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 163억 달러의 시장 규모에 도달할 것으로 예상되며, 2023-2030년 분석 기간 동안 15.5%의 CAGR을 기록할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 15.2%와 14.2%의 CAGR을 기록할 것으로 예상됩니다. 유럽에서는 독일이 약 12.1%의 CAGR로 성장할 것으로 예상됩니다.
세계 펨테크 시장 - 주요 동향 및 촉진요인 요약
왜 펨테크가 세계 헬스케어 분야에서 큰 견인차 역할을 하는가?
펨테크는 여성을 위한 기술의 약자로, 여성의 건강과 웰빙을 위한 기술과 혁신에 초점을 맞춘 세계 헬스케어 분야에서 빠르게 성장하고 있는 분야입니다. 이 시장에는 디지털 건강 솔루션, 웨어러블, 모바일 앱, 진단 도구, 생식 건강, 임신 관리, 갱년기, 월경 건강, 불임, 성 건강, 일반 건강 등의 문제를 다루는 제품 등이 포함됩니다. 여성 특유의 헬스케어 니즈에 대한 인식이 높아짐에 따라, 펨테크는 그동안 헬스케어 혁신에서 미비했던 솔루션을 제공하는 중요한 존재로 부상하고 있습니다.
펨테크가 부상하는 주요 이유 중 하나는 모바일 기술, 웨어러블 기기, 디지털 건강 플랫폼에 대한 접근성 등의 발전에 힘입어 여성들이 자신의 건강을 통제할 수 있는 힘이 커졌기 때문입니다. 여성들은 생리 주기 추적, 생식력 모니터링, 임신 관리, 원격의료 서비스 이용에 점점 더 많은 기술을 활용하고 있으며, 건강 관리에 대한 의사결정에 더 큰 자율성을 갖게 되었습니다. 또한, 폐경과 월경 장애와 같은 많은 여성 건강 문제는 오랫동안 전통적인 의료 서비스 제공자가 제대로 된 서비스를 제공하지 않아 펨테크 솔루션이 현재 해결해야 할 틈새를 남기고 있습니다. 이러한 여성 특유의 생물학적 요구에 대응하는 맞춤형 헬스케어 솔루션에 대한 수요가 급증하면서 펨테크의 급격한 성장을 견인하고 있습니다.
또한, 성 평등으로 나아가는 사회적 변화와 여성 건강 문제에 대한 관심이 높아지면서 이 시장에 대한 관심이 높아지고 있습니다. 공중보건 캠페인, 여성 지도층의 증가, 여성 기업가들의 부상 등은 여성을 위한 혁신적인 헬스케어 솔루션을 촉진하는 데 기여하고 있습니다. 정부, 의료 서비스 제공자, 투자자들이 여성 건강에 더 효과적으로 대처하는 것이 경제적, 사회적 이익을 가져온다는 것을 인식함에 따라 펨테크는 전 세계적으로 큰 지지를 받고 있으며, 보다 종합적인 헬스케어 기술을 위한 길을 열어가고 있습니다.
기술의 발전은 펨테크 솔루션을 어떻게 향상시키고 있는가?
기술의 발전은 여성 건강 솔루션의 기능, 접근성, 개인화를 향상시키며 펨테크에 혁명을 일으키고 있습니다. 가장 중요한 펨테크 혁신 중 하나는 여성들이 생식과 관련된 다양한 측면을 추적하고 관리할 수 있는 모바일 건강(mHealth) 앱의 등장으로, Clue, Flo, Natural Cycles와 같은 앱은 사용자가 생리 주기를 모니터링하고 배란을 예측하며, 생식 능력과 건강 전반에 대한 증상을 추적할 수 있게 해줍니다. 생식 능력과 건강 전반에 대한 인사이트를 제공합니다. 이러한 앱은 인공지능(AI)과 머신러닝 알고리즘을 사용하여 데이터를 분석하고 개인화된 추천을 제공함으로써 여성들이 자신의 건강 패턴을 쉽게 이해할 수 있도록 돕습니다. 또한, 이러한 디지털 플랫폼은 여성에게 맞춤화된 건강 인사이트를 제공함으로써 피임, 불임 치료 및 일반적인 건강에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
웨어러블 기술은 펨테크의 또 다른 주요 발전 분야입니다. 스마트 팔찌나 패치와 같은 웨어러블 기기에는 생체 신호, 호르몬 수치 및 기타 여성 건강과 관련된 생리적 지표를 모니터링하는 센서가 장착되어 있습니다. 예를 들어, 아바(Ava)와 같은 웨어러블 기기는 생리적 데이터를 활용해 가임 기간을 추적하고 여성이 비침습적으로 임신 계획을 관리할 수 있는 방법을 제공합니다. 이러한 기기들은 생체 감지 기술의 발전으로 더욱 정교해져 호르몬 변화, 스트레스 수준, 수면 패턴 등 생식 및 건강 전반에 직접적인 영향을 미치는 요소들을 실시간으로 모니터링할 수 있게 되었습니다. 웨어러블과 스마트폰 앱의 통합은 종합적인 건강 추적 및 분석을 위한 데이터 동기화를 통해 사용자 경험을 향상시킵니다.
원격의료 및 원격진료 서비스의 발전은 펨테크 시장을 더욱 확대시키고 있습니다. 가상 헬스케어 플랫폼은 특히 임산부 관리, 성 건강, 갱년기 관리 등의 분야에서 여성들이 의료 상담에 더 쉽게 접근할 수 있도록 돕고 있습니다. 여성 건강에 특화된 원격의료 서비스는 환자가 직접 병원을 방문하지 않고도 전문가의 조언, 처방전, 치료 옵션을 받을 수 있는 편리한 방법을 제공합니다. 이러한 접근성은 전문 의료 서비스에 대한 접근성이 제한적일 수 있는 지방이나 의료 서비스가 부족한 지역에 거주하는 여성들에게 특히 유용합니다. 원격의료와 AI 기반 진단의 부상으로 펨테크는 보다 편리하고 개인화된, 즉각적인 접근성을 제공함으로써 여성들의 치료의 질을 향상시키고 있습니다.
소비자 취향의 변화와 사회 트렌드가 펨테크 시장을 어떻게 형성하고 있는가?
소비자 취향의 변화와 사회적 트렌드는 세계 펨테크 시장을 형성하는 데 중요한 역할을 하고 있습니다. 특히 더 많은 여성들이 개인화되고 편리하며 접근하기 쉬운 헬스케어 솔루션을 원하고 있습니다. 이러한 추세의 주요 원동력 중 하나는 자가 관리와 예방 의료에 대한 관심의 증가입니다. 여성들은 건강 관리에 더욱 적극적으로 참여하며 자신의 신체적, 정신적 건강을 추적, 이해 및 개선할 수 있는 도구를 찾고 있습니다. 불임 추적 앱, 생리 관리 도구, 갱년기 지원 기기 등 펨테크 솔루션은 기존의 의료 서비스 제공자에게만 의존하지 않고 여성의 고유한 요구를 관리할 수 있는 맞춤형 건강 관리 옵션을 제공함으로써 이러한 추세에 부합합니다.
성별에 따른 건강관리 문제에 대한 인식이 높아지면서 소비자 행동에도 영향을 미치고 있습니다. 수십 년 동안 생리통, 자궁내막증, 갱년기 장애와 같은 여성 건강 문제는 과소 진단되거나 과소 조사되어 왔습니다. 이러한 의료 서비스의 격차는 여성들의 요구에 특화된 전문 솔루션에 대한 수요로 이어지고 있습니다. 소비자들은 호르몬 모니터링 웨어러블부터 골반저근육 트레이너에 이르기까지 이러한 문제에 대한 진정한 해결책을 제시하는 제품과 서비스를 원하고 있으며, 이는 펨테크 혁신의 새로운 길을 열어주고 있습니다. 이러한 추세는 스마트 케겔 트레이너, 성 건강 교육을 제공하는 앱 등 성 건강 관리에 도움이 되는 제품에 대한 수요에도 반영되어 보다 종합적인 여성 건강 관리에 기여하고 있습니다.
헬스케어를 포함한 모든 분야에서 남녀 평등과 대표성을 추구하는 사회적 움직임도 펨테크 시장을 형성하는 중요한 트렌드입니다. 여성 기업가, 혁신가, 헬스케어 전문가들이 여성 건강 관련 제품 및 서비스 개발을 주도하고 있으며, 이러한 요구가 더 넓은 헬스케어 시스템에서 우선순위를 차지할 수 있도록 노력하고 있습니다. 또한, 투자자들이 이 시장의 미개척 잠재력과 수익성을 인식하면서 펨테크 스타트업에 대한 벤처 캐피털의 투자도 증가하고 있습니다. 또한, 생식권, 성 및 생식 관련 권리, 의료에서의 성 평등, 여성 건강 문제의 낙인 제거와 같은 논의는 펨테크 기업들이 인지도를 높이고 제품을 더 효과적으로 판매할 수 있도록 돕고 있습니다.
또한, 디지털 플랫폼과 소셜 미디어의 등장으로 펨테크 기업들은 소비자와 직접 소통할 수 있게 되었고, 이는 헬스케어에 대한 커뮤니티 주도의 접근 방식을 만들어내고 있습니다. 많은 펨테크 브랜드들이 소셜 미디어를 통해 생리, 불임, 폐경 등 그동안 금기시되어 왔던 주제를 다루며 여성의 건강에 대해 교육하고 힘을 실어주는 데에 소셜 미디어를 활용하고 있습니다. 기업과 소비자 간의 이러한 개방적인 대화는 여성들이 자신의 건강 문제에 대해 더 쉽게 이야기하고 자신에게 맞는 해결책을 찾을 수 있는 보다 종합적인 환경을 조성하고 있습니다. 이러한 소비자 선호도의 변화는 성 평등과 투명성을 추구하는 사회적 추세와 함께 펨테크 시장의 성장을 촉진하고 여성들에게 보다 개인화된 건강 관리 경험을 제공하고 있습니다.
펨테크 세계 시장 성장 원동력은?
세계 펨테크 시장의 성장은 여성 건강 솔루션에 대한 투자 증가, 기술 혁신, 개인화된 헬스케어에 대한 소비자 수요 증가 등 몇 가지 중요한 요인에 의해 주도되고 있습니다. 이러한 성장의 주요 촉진요인 중 하나는 펨테크의 큰 시장 잠재력을 인식한 벤처 캐피탈과 헬스케어 투자자들의 관심과 자금 조달이 증가하고 있다는 점입니다. 역사적으로 여성 건강은 헬스케어 혁신에서 자금이 부족하고 대표성이 부족했지만, 최근 몇 년 동안 업계가 전문적인 제품 및 서비스의 필요성을 인식함에 따라 투자가 급증하고 있습니다. 생식 건강, 산모 관리, 갱년기 관리를 전문으로 하는 펨테크 스타트업들이 큰 주목을 받고 있으며, 몇몇 회사들은 최첨단 제품을 개발하고 시장 입지를 확대하기 위해 대규모 자금을 확보했습니다.
또 다른 성장의 원동력은 여성 건강 문제에 대한 인식의 확대와 예방의학으로의 전환입니다. 웨어러블 기술과 모바일 헬스 앱의 등장으로 여성들은 생리주기 추적, 생식력 모니터링, 만성질환 관리 등을 통해 실시간으로 자신의 건강을 관리할 수 있게 되었습니다. 이러한 기술은 여성들이 정보에 입각한 건강관리 결정을 내리고, 필요한 시기에 조기 개입을 요청할 수 있게함으로써 기존 의료 시스템의 부담을 줄이고 장기적인 건강 결과를 촉진할 수 있도록 돕습니다. 예방 의료 솔루션, 특히 불임 관리 및 임신 관리와 같은 분야에 대한 수요는 펨테크 시장을 더욱 확대할 것으로 예상됩니다.
여성 건강 개선에 대한 전 세계의 관심이 높아진 것도 펨테크의 채택을 촉진하는 데 중요한 역할을 하고 있습니다. 전 세계 정부와 의료 기관들은 생식 건강 관리 접근성 개선부터 더 나은 산전 산후 관리 서비스 제공에 이르기까지 여성 건강 문제를 해결하기 위한 이니셔티브를 시작하고 있습니다. 이는 특히 의료 접근성이 제한된 개발도상국에서 더욱 두드러지는데, 펨테크 솔루션은 여성 건강 관리의 격차를 해소할 수 있는 효율적인 방법을 제공합니다. 원격의료, 교육 자료 및 건강 추적 도구에 대한 액세스를 제공하는 모바일 건강 플랫폼은 이러한 지역에서 특히 가치가 높으며, 시장 성장을 촉진하고 건강 형평성을 향상시킬 수 있습니다.
마지막으로, 웰빙과 개인화된 건강 관리를 추구하는 사회적 트렌드가 펨테크 시장의 성장에 크게 기여하고 있습니다. 소비자들이 자가 관리와 개인화된 건강 솔루션을 점점 더 우선시함에 따라, 펨테크 제품은 모든 연령대의 여성들에게 웰빙 루틴의 중요한 구성요소로 자리 잡고 있습니다. 펨테크는 불임 추적 장치 및 앱에서 호르몬 모니터링 웨어러블, 골반 건강 솔루션에 이르기까지 실시간 인사이트와 맞춤형 관리를 제공하는 제품을 제공하여 여성들이 자신의 건강 상태를 보다 쉽게 관리할 수 있도록 돕고 있습니다. 개인화된 하이테크 기반 헬스케어에 대한 수요 증가는 펨테크의 기술 혁신과 투자를 촉진하고 세계 시장에서 지속적인 성장을 위한 발판을 마련하고 있습니다.
투자 증가, 기술 발전, 예방적이고 개인화된 케어에 대한 소비자 수요 증가, 여성 건강 개선에 대한 전 세계적인 관심 증가로 인해 펨테크 세계 시장은 빠르게 성장하고 있습니다. 헬스케어 산업이 여성의 건강을 우선시하고 오랜 기간 동안 지속된 의료 격차를 해소하기 위해 노력하는 가운데, 펨테크는 전 세계 여성 건강 관리의 미래를 변화시키는 데 중요한 역할을 하고 있습니다.
조사 대상 기업 예시(총 39건)
Aavia
Allara Health
Athena Feminine Technologies, Inc.
BioWink GmbH(Clue)
Bloomlife
Canopie Inc.
Coroflo Limited
Flo Health
Glow Inc.
LunaJoy
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 성장 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
ksm
영문 목차
영문목차
Global FemTech Market to Reach US$107.0 Billion by 2030
The global market for FemTech estimated at US$36.6 Billion in the year 2023, is expected to reach US$107.0 Billion by 2030, growing at a CAGR of 16.6% over the analysis period 2023-2030. FemTech Devices, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$38.8 Billion by the end of the analysis period. Growth in the FemTech Software segment is estimated at 18.1% CAGR over the analysis period.
The U.S. Market is Estimated at US$9.6 Billion While China is Forecast to Grow at 15.5% CAGR
The FemTech market in the U.S. is estimated at US$9.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$16.3 Billion by the year 2030 trailing a CAGR of 15.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.2% and 14.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.1% CAGR.
Global FemTech Market – Key Trends & Drivers Summarized
Why Is FemTech Gaining Major Traction in the Global Healthcare Landscape?
FemTech, short for female technology, has emerged as a rapidly growing segment in the global healthcare landscape, focusing on technology and innovations that cater to women’s health and wellness needs. This market includes digital health solutions, wearables, mobile apps, diagnostic tools, and products that specifically address issues such as reproductive health, pregnancy care, menopause, menstrual health, fertility, sexual health, and general wellness. With increasing awareness of women’s unique healthcare needs, FemTech is becoming a critical player in providing solutions that have been historically underrepresented in healthcare innovation.
One of the key reasons for the rise of FemTech is the increasing empowerment of women to take control of their health, supported by advancements in mobile technology, wearable devices, and access to digital health platforms. Women are increasingly turning to technology to track menstrual cycles, monitor fertility, manage pregnancy, and access telemedicine services, giving them greater autonomy over their healthcare decisions. Additionally, many women’s health issues, such as menopause or menstrual disorders, have long been underserved by traditional healthcare providers, leaving a gap that FemTech solutions are now addressing. This surge in demand for personalized healthcare solutions that cater to women’s unique biological needs is driving the rapid growth of FemTech.
Furthermore, societal shifts toward gender equality and increased focus on women’s health issues have brought more attention to this market. Public health campaigns, greater representation of women in leadership positions, and the rise of women entrepreneurs have all contributed to the push for more innovative healthcare solutions for women. As governments, healthcare providers, and investors recognize the economic and social benefits of addressing women’s health more effectively, FemTech is gaining significant traction worldwide, paving the way for more inclusive healthcare technologies.
How Are Technological Advancements Enhancing FemTech Solutions?
Technological advancements are revolutionizing FemTech by improving the functionality, accessibility, and personalization of women’s health solutions. One of the most significant innovations in FemTech has been the rise of mobile health (mHealth) apps that allow women to track and manage various aspects of their reproductive health. Apps like Clue, Flo, and Natural Cycles enable users to monitor their menstrual cycles, predict ovulation, and track symptoms, offering insights into fertility and overall health. These apps use artificial intelligence (AI) and machine learning algorithms to analyze data and provide personalized recommendations, making it easier for women to understand their unique health patterns. Additionally, these digital platforms empower women to make informed decisions about contraception, fertility treatments, and general health by providing them with tailored health insights.
Wearable technology is another major area of advancement within FemTech. Wearable devices, such as smart bracelets and patches, now come equipped with sensors that monitor vital signs, hormone levels, and other physiological metrics related to women’s health. For example, wearables like Ava use physiological data to track fertility windows, offering non-invasive ways for women to manage fertility planning. These devices are becoming more sophisticated, with advancements in biosensing technologies that allow for real-time monitoring of hormone fluctuations, stress levels, and even sleep patterns—factors that directly impact reproductive and overall health. The integration of wearables with smartphone apps also enhances user experience by syncing data for comprehensive health tracking and analysis.
Advances in telemedicine and remote healthcare services are further expanding the FemTech market. Virtual healthcare platforms are making it easier for women to access medical consultations, especially in areas such as prenatal care, sexual health, and menopause management. Telemedicine services that specialize in women’s health offer a convenient way for patients to receive expert advice, prescriptions, and treatment options without needing to visit a clinic in person. This accessibility is particularly valuable for women living in rural or underserved areas, where access to specialized healthcare may be limited. With the rise of telemedicine and AI-powered diagnostics, FemTech is improving the quality of care for women by making it more convenient, personalized, and readily available.
How Are Changing Consumer Preferences and Societal Trends Shaping the FemTech Market?
Changing consumer preferences and societal trends are playing a crucial role in shaping the global FemTech market, particularly as more women demand personalized, convenient, and accessible healthcare solutions. One of the key drivers of this trend is the increasing focus on self-care and preventive health. Women are becoming more proactive about managing their health, seeking tools that enable them to track, understand, and improve their physical and mental well-being. FemTech solutions, such as fertility tracking apps, period management tools, and menopause support devices, align with this trend by offering customized healthcare options that help women manage their unique needs without relying solely on traditional healthcare providers.
The increasing awareness of gender-specific healthcare challenges is also influencing consumer behavior. For decades, women's health issues, such as menstrual disorders, endometriosis, and menopause, were either underdiagnosed or under-researched. This gap in healthcare services has led to a demand for specialized solutions that cater specifically to women's needs. Consumers are seeking products and services that provide real solutions to these issues, from hormone-monitoring wearables to pelvic floor trainers, which have opened up new avenues for FemTech innovation. These trends are also reflected in the demand for products that help manage sexual health, such as smart Kegel trainers or apps that provide sexual health education, all of which contribute to more comprehensive women’s health management.
The societal push for gender equality and representation in all sectors, including healthcare, is another important trend shaping the FemTech market. Women entrepreneurs, innovators, and healthcare professionals are leading the charge in developing products and services that cater to women’s health, ensuring that these needs are prioritized within the broader healthcare system. This has also resulted in more venture capital investment into FemTech startups, as investors recognize the untapped potential and profitability of the market. Additionally, discussions around reproductive rights, gender parity in healthcare, and the destigmatization of women’s health issues have made it easier for FemTech companies to gain visibility and market their products more effectively.
Moreover, the rise of digital platforms and social media has enabled FemTech companies to engage directly with consumers, creating a community-driven approach to healthcare. Many FemTech brands use social media to educate and empower women about their health, addressing topics that have historically been considered taboo, such as menstruation, fertility, and menopause. This open dialogue between companies and consumers is creating a more inclusive environment, where women feel more comfortable discussing their health needs and seeking solutions tailored specifically for them. These changing consumer preferences, coupled with societal trends toward gender equality and transparency, are driving growth in the FemTech market and creating a more personalized healthcare experience for women.
What Is Driving the Growth of the Global FemTech Market?
The growth of the global FemTech market is being driven by several key factors, including increased investment in women’s health solutions, technological innovation, and rising consumer demand for personalized healthcare. One of the primary drivers of this growth is the increasing attention and funding from venture capitalists and healthcare investors who recognize the significant market potential in FemTech. Historically, women’s health has been underfunded and underrepresented in healthcare innovation, but recent years have seen a surge in investment as the industry acknowledges the need for specialized products and services. FemTech startups focusing on reproductive health, maternal care, and menopause management have gained substantial traction, with several companies securing large rounds of funding to develop cutting-edge products and expand their market presence.
Another significant driver of growth is the expanding awareness of women’s health issues and the shift toward preventive care. With the rise of wearable technology and mHealth apps, women are increasingly able to take control of their health by tracking their menstrual cycles, monitoring fertility, and managing chronic conditions in real time. These technologies empower women to make informed healthcare decisions and seek early interventions when needed, reducing the burden on traditional healthcare systems and promoting long-term health outcomes. The demand for preventive health solutions, particularly in areas like fertility management and pregnancy care, is expected to drive further expansion of the FemTech market.
The growing global focus on improving women’s health outcomes is also playing a key role in driving FemTech adoption. Governments and healthcare organizations worldwide are launching initiatives aimed at addressing women’s health challenges, from improving access to reproductive healthcare to providing better maternal care services. This is particularly evident in developing regions where access to healthcare is limited, and FemTech solutions offer an efficient way to bridge the gap in women’s healthcare. Mobile health platforms that provide access to telemedicine, educational resources, and health tracking tools are particularly valuable in these areas, driving market growth and improving health equity.
Lastly, societal trends toward wellness and personalized healthcare are significantly contributing to the growth of the FemTech market. As consumers increasingly prioritize self-care and personalized health solutions, FemTech products are becoming a key component of wellness routines for women of all ages. From fertility tracking devices and apps to hormone-monitoring wearables and pelvic health solutions, FemTech offers products that provide real-time insights and customized care, making it easier for women to manage their health on their own terms. This rising demand for personalized and tech-driven healthcare is encouraging innovation and investment in FemTech, positioning it for continued growth in the global market.
The combination of increased investment, technological advancements, growing consumer demand for preventive and personalized care, and a global focus on improving women’s health outcomes is driving the rapid expansion of the global FemTech market. As the healthcare industry continues to prioritize women's health and address long-standing gaps in care, FemTech is poised to play a pivotal role in transforming the future of healthcare for women worldwide.
Select Competitors (Total 39 Featured) -
Aavia
Allara Health
Athena Feminine Technologies, Inc.
BioWink GmbH (Clue)
Bloomlife
Canopie Inc.
Coroflo Limited
Flo Health
Glow Inc.
LunaJoy
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
FemTech - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Focus on Womens Health and Wellness Propels Growth in FemTech Market
Case Overview: Growth in Digital Health Platforms Fuels Adoption of FemTech Solutions
Technological Innovations in Fertility Tracking and Reproductive Health Strengthen Business Case for FemTech
Focus on Menstrual Health and Hormonal Wellness Drives Market Adoption of FemTech Apps
Increasing Investments in Women-Centric Startups Expands Opportunities for FemTech Innovations
Case Overview: Rising Popularity of Telemedicine and Virtual Healthcare Bodes Well for FemTech Market Growth
Focus on Maternal and Prenatal Care Strengthens Market Adoption of FemTech Solutions
Focus on Sexual Health and Wellness Drives Innovation in FemTech Products and Services
Increasing Use of FemTech for Mental Health and Wellbeing Strengthens Market Opportunities
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World FemTech Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for FemTech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for FemTech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for FemTech by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Consumer Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Consumer Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Consumer Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Direct-to-Consumer End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Direct-to-Consumer End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Direct-to-Consumer End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Fertility Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 30: World Historic Review for Fertility Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: World 16-Year Perspective for Fertility Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 33: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: World 16-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 35: USA Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: USA Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: USA 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
TABLE 38: USA Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: USA Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: USA 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
CANADA
TABLE 41: Canada Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: Canada Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: Canada 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
TABLE 44: Canada Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Canada Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: Canada 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
JAPAN
FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 47: Japan Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Japan Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Japan 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
TABLE 50: Japan Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Japan Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Japan 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
CHINA
FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 53: China Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: China Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: China 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
TABLE 56: China Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: China Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: China 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
EUROPE
FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 59: Europe Recent Past, Current & Future Analysis for FemTech by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 60: Europe Historic Review for FemTech by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: Europe 16-Year Perspective for FemTech by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 62: Europe Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: Europe Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: Europe 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
TABLE 65: Europe Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: Europe Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: Europe 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
FRANCE
FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 68: France Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: France Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: France 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
TABLE 71: France Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: France Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: France 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
GERMANY
FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 74: Germany Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Germany Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Germany 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
TABLE 77: Germany Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: Germany Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Germany 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
ITALY
TABLE 80: Italy Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Italy Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Italy 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
TABLE 83: Italy Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Italy Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Italy 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
UNITED KINGDOM
FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 86: UK Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: UK Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: UK 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
TABLE 89: UK Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: UK Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: UK 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Rest of Europe Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Rest of Europe 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Rest of Europe Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Rest of Europe 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
ASIA-PACIFIC
FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Asia-Pacific 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Asia-Pacific 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 104: Rest of World Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Rest of World Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Rest of World 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
TABLE 107: Rest of World Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: Rest of World Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Rest of World 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030